Events

The 8th CRISPR AgBio Congress is the leading forum for AgBiotech innovators, seed companies, growers, consumer food brands, and investors to accelerate the commercialization of gene-edited crops. With USDA easing regulatory pathways and AI revolutionizing trait discovery, now is the time to position your organization at the forefront of sustainable agriculture. Join industry leaders, including Pairwise, Corteva, Bayer Crop Science, BASF, and more to explore next-generation CRISPR tools, AI-driven target discovery, and strategies for navigating global regulations. New for 2026: Global Regulations and IP Focus Day, a dedicated Driving Consumer Acceptance Panel, and expanded sessions on AI applications in AgBio. Be part of the only event combining technical breakthroughs with commercial know-…

Join leading experts at the Pediatrics and Neonatology Conference to explore the latest advancements in child healthcare, pediatric research, and neonatal medicine. The event covers innovative treatments, clinical practices, and emerging pediatric technologies.

The 11th Innate Killer Summit continues its legacy as the world's leading industry meeting dedicated exclusively to advancing NK and innate immune cell therapies. This year, the summit unites pioneering biotechs, including NKGen, NKILT, Senti Bio, NKore, and leaders from the MD Anderson Rizvani Lab, alongside translational scientists and platform innovators to showcase breakthrough progress in engineering, manufacturing, persistence, tumor targeting, and clinical translation. As the NK space becomes increasingly competitive and the path to differentiation narrows, this summit stands firmly alongside the global NK community, providing the clarity, collaboration, and momentum needed to keep innovation moving forward. With in-depth scientific content, real-world clinical insights across six c…

This webinar, featuring Prof. Nikolai Petrovsky, explores how recent research and tools like artificial intelligence are unlocking the broad pharmaceutical utility of polysaccharides, using inulin as a key case study. Highlights of the presentation Chemistry and properties of polysaccharidesResearch tools for polysaccharidesSolving polysaccharide structures using AIPharmaceutical utility of polysaccharides  

Gene therapy is entering a defining new chapter. After a period of challenge and recalibration, the field is regaining momentum, driven by teams who remain steadfast in their belief that this science can transform lives. Confidence is returning, with significant investments and acquisitions signalling a renewed commitment to overcoming barriers of safety, efficacy, and scalability. The 9th Gene Therapy Development Summit returns to Boston as the meeting point for this community. Join 100+ leading voices from the likes of Bayer, Astellas Pharmaceuticals, REGENXBIO, Ocugen, AskBio, CureDuchenne Ventures, and more to come together to share ideas, restore confidence, and chart a sustainable path forward for gene therapy. Connect with your peers in pre-clinical development, manufacturing, analy…

9TH ANNUAL PHARMA REGULATORY SUMMIT 2026   “Driving Regulatory Excellence for a Changing Pharma Landscape”   24th March 2026, Hotel Kohinoor Continental, Mumbai, India   The 9th Annual Pharma Regulatory Summit 2026 congregates foremost global pharmaceutical industry professionals and regulators to share their insights on technologies, approaches, and solutions that will drive innovation and quality for the medicines delivered to patients worldwide. This interactional setting with expert-led regulatory and industry presentations will ensure pharmaceutical industry professionals to develop and apply ingenious solutions in today’s Indian pharma ecosystem.   Sponsor / Delegate Registration E-mail - kavitha@virtueinsight.co.in or M: +91 9361957193 DELEGATE REGISTRATION : &nb…

CMAC Open Days 2026: Join us 24–26 March 2026 as we celebrate 15 years of CMAC transforming medicines manufacturing. Discover how Industry 5.0 technologies are shaping the future of medicines manufacturing, with insights into the latest trends, tools, and strategies for creating future-ready, resilient and sustainable manufacturing processes. At the Open Days you’ll: 🤝 Network with top academics, industry leaders, and researchers 👩‍🔬 Engage in interactive sessions, lab tours, and poster presentations 💊 Learn about the latest innovations tackling real-world pharmaceutical challenges 🎟️ Registration is now open! Take advantage of early bird rates available until Monday 2 February 2026: £100 standard (rising to £125 after early bird) £80 PhD student (rising to £90 after early bird)

To,    I have reached out to you as your research areas/products/services are related to our upcoming conference. Considering the same, our organizing committee would like to invite to be a part of it and you will be a great fit for our upcoming “World Congress on Advances in Applied Science and Engineering” held during 25-26 March 2026. at London, United Kingdom   The WASE 2026 aims to bring together leading researchers, academicians, industry professionals, and policymakers to share innovations, exchange ideas, and foster collaboration across a wide range of topics. We extend warm invitation to you and your organization to be a part of the conference as a Sponsors/Exhibitor/Speaker/Delegate.   Let me know your interest in the same, accordingly I will share y…

The International Conference on Cardiology and Cardiovascular Science will take place from March 26-28, 2026, in Singapore and online, providing a unique opportunity for medical professionals, academics, and industry leaders to engage in high-level discussions on cardiac health. With sessions in Cardiology Conferences 2026 covering everything from advancements in cardiac electrophysiology to the role of AI in diagnosing cardiovascular diseases, these Cardiology Conferences are set to shape the future of heart disease prevention and treatment. By attending Cardiology Conference, participants will benefit from exposure to the latest research, practical training sessions, and exclusive networking opportunities with top-tier cardiologists and medical innovators. The Cardiovascular Science Conf…

LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers Squibb/Orbital Therapeutics. Validating LNPs as a stand-out delivery vehicle for cell and gene therapies! Returning to Boston in April 2026, the 5th LNP Formulation and Process Development Summit is an industry-led end-to-end meeting providing the latest scientific content to advance LNP development for a variety of payloads and therapeutic applications, from mRNA vaccines to next-generation cell and gene therapies. This is your one-stop shop to hear insights on LNP discovery, analytics, formulation, process development and large-scale manufacturing. With 3 focused streams, Analytical Development and…

EDUCATION IS OUR TOP PRIORITY!With education documentation becoming a way of life and the budget constraints facing many hospitals and institutions, in conjunction with the Society of Interventional Radiology (SIR) and the Association for Radiologic and Imaging Nursing (ARIN), AVIR strives to build an education program that meets and exceeds the expectations of our attendees. The AVIR Annual Scientific Meeting continues to provide an excellent venue for participation and marketing for our corporate sponsors. AVIR MISSIONis to grow, advance, and continue education in the area of vascular and interventional radiology and to promote professional growth and resources for AVIR members throughout the medical community.The AVIR is comprised of department managers, chief technologists, directors a…

Neuroimmunology is entering a defining moment. With the $470M buyout of Vigil's TREM2 asset, Ventus' NLRP3 inhibitor in phase 2a, and promising phase 3 BTKi readouts from Sanofi and Roche, the field is beginning to show encouraging signs of clinical viability in targeting neuroinflammation. Now the real race begins. Uncovering the next wave of mechanisms, biomarkers, and translational strategies that will move beyond today's successes and unlock new therapeutic frontiers in neurodegeneration and neuroimmune-driven psychiatric disease. The 8th Neuroimmunology Drug Development Summit is the industry's only meeting fully dedicated to advancing novel neuroinflammatory targets, uniquely bridging cutting-edge academic discovery with the practical lens of drug development. This year's expanded pr…

Thought Leader Texas is a premier gathering for executives, innovators, and industry leaders who want to stay ahead of fast-moving shifts in business, leadership, and organizational strategy. This summit brings together experts from across sectors to share fresh perspectives, practical insights, and proven approaches that help leaders navigate today’s most pressing challenges. Through keynote talks, panel discussions, and interactive sessions, attendees will explore themes such as leadership development, talent and culture, operational excellence, technology adoption, and long-term strategic growth. Each session is designed to offer actionable takeaways-clear ideas and tools executives can bring back to their organizations. The event also creates space for meaningful networking, allowing l…

Europe's oligonucleotide landscape is entering a pivotal growth phase. With the €21M launch of Aerska and major collaborations such as Novartis and SciNeuron, Lundbeck and Contera, and Secarna and Vect-Horus, European biopharma are rapidly advancing RNA-targeted approaches to address previously undruggable CNS diseases.  In response to this momentum, the inaugural Oligonucleotides for CNS Summit Europe will unite 60+ senior industry leaders for the first European forum dedicated exclusively to CNS-focused Oligonucleotide therapeutics.  The summit delivers three days of highly technical, data-driven discussions addressing the challenges unique to CNS development with insight into next-generation BBB delivery strategies beyond TfR1, advanced in vivo and iPSC models, novel chemistry…

The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…

The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…

One foundation. Cross-functional strength. Elevated impact. For years, the question was: What do we build next? More sophisticated AI. More advanced engagement models. Wider access strategies. Each impressive. Each reaching higher. Then market winds shifted. New regulations arrived. Suddenly, the question changed: Can our foundations hold? Walls between functions preventing flexibility. Disconnected data infrastructure fragmenting insights. Inefficiencies becoming liabilities under pressure. Those walls aren't load-bearing, they're removable. That data infrastructure can reinforce decisions. And patient purpose? That's the force binding everything together. You must underpin your customer engagement strategy with reimagined data and infrastructure. You must reprioritise your launch plans t…

The conference features a comprehensive pre-conference focus day dedicated to advancements in device design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the most pressing industry challenges and breakthrough solutions including: Device Innovations for Large Volume and Novel Drug Product DeliveryAdvancing Sustainability in the Injectable Device IndustryPrimary Packaging: Ensuring Safe, Stable, and Biocompatible Combination ProductsPatient-Driven Device Design Date and Time: Monday, 27 April 2026 at 08:30 - Wednesday, 29 April 2026 at 17:00

Optimizing ADC Physiochemical, Potency, and Impurity Analytical Methods to Enhance Product Understanding, Quality and Assess DARs for Regulatory Submissions The 5th ADC Analytical Development Summit is the only dedicated platform for tackling the unique analytical complexities of ADC development, bringing together technical leaders to ensure a high-quality, regulatory-compliant ADC product. The ADC landscape is undergoing a rapid transformation with novel modalities like bispecifics, dual payload conjugates, and novel conjugates all push the boundaries of innovation, whilst more traditional ADCs are progressing their way through the pipelines - analytical teams are facing greater challenges in ensuring product quality and regulatory compliance than ever. The 5th ADC Analytical Development…

The GPCR field is experiencing a renaissance, driven by renewed investment, clinical progress, and next-generation technologies unlocking hundreds of previously untargeted receptors. With rapid advances in structural biology, computation, and screening, the race is on to validate new GPCRs, understand dynamic activation mechanisms, and develop assays that better predict therapeutic efficacy and guide smarter candidate selection. Returning as the only industry-led meeting dedicated to GPCR drug discovery, the 5th GPCR-Targeted Drug Discovery Summit features a jam-packed agenda featuring new expert voices, and fresh insights spanning the latest targets, tools, and therapeutic strategies. Join 80+ GPCR-focused leaders across biopharma to share insights, build collaborations, and accelerate ne…